Here's Why Pfizer's COVID Revenue Could Remain Strong Next Year

Here's Why Pfizer's COVID Revenue Could Remain Strong Next Year

Submitted by admin on June 1, 2022 - 7:33pm
Source: 
Motley Fool
News Tags: 
Pfizer
COVID-19
vaccines
Paxlovid
Headline: 
Here's Why Pfizer's COVID Revenue Could Remain Strong Next Year
snippet: 
  • Pfizer's business will get a big boost from COVID-19 revenue this year.
  • Next year is less certain, but the drugmaker still has multiple opportunities.
  • One potentially promising revenue stream could be considered to treat long COVID.

Do Not Allow Advertisers to Use My Personal information